8-K: Owlet Settles Derivative Suit, Boosts Governance

Sentiment:

Legal Settlement Update 24 September 2025 4:07 PM

Owlet, Inc. has received preliminary court approval for a settlement in a shareholder derivative lawsuit, agreeing to implement significant corporate governance reforms and pay $675,000 in legal fees.

Summary

Owlet, Inc. has obtained preliminary court approval for a settlement in the Vargas v. Workman, et al. shareholder derivative action.
The lawsuit, brought derivatively on behalf of the Company, challenged certain statements regarding the 'Smart Sock' product.
As part of the settlement, Owlet has agreed to implement and maintain specific corporate governance, oversight, and internal controls reforms for a period of not less than eight years.
The settlement includes a release of claims related to the allegations in the Derivative Action, with no admission of wrongdoing by the Company or its directors.
Owlet is responsible for the payment of attorneys' fees and expenses totaling $675,000.00 to Plaintiffs' Counsel, subject to court approval.
Plaintiffs Janet Vargas and Nathan Capleton will each receive a $2,000.00 service award from the Fee and Expense Amount.
The settlement will result in the dismissal of all claims asserted in the Derivative Action with prejudice upon final court approval.

Sentiment

Score: 7

Explanation: The settlement resolves a significant legal overhang and introduces substantial corporate governance improvements, which are positive for long-term stability and investor confidence. However, the need for such a lawsuit and the associated legal fees reflect past deficiencies.

Positives

Resolution of a significant shareholder derivative lawsuit, removing legal uncertainty and potential future litigation costs.
Implementation of robust corporate governance reforms designed to strengthen internal controls, risk management, and disclosure practices.
Establishment of a Board-level Audit and Risk Committee with independent members and enhanced oversight responsibilities.
Formation of a management-level Enterprise Risk Management (ERM) Committee to assess and report on organizational risks.
Creation of a management-level Disclosure Committee to ensure accuracy, completeness, and timeliness of public disclosures.
Mandatory director education programs and limitations on the number of public company boards directors can serve on, promoting focused oversight.

Negatives

The Company is required to pay $675,000.00 in attorneys' fees and expenses as part of the settlement.
The lawsuit stemmed from alleged material misstatements and omissions about the business and failure to implement effective internal controls over regulatory compliance, indicating past deficiencies.

Risks

The settlement is subject to final court approval, which is scheduled for February 6, 2026.
Failure to effectively implement and maintain the agreed-upon corporate governance reforms could lead to future compliance issues or shareholder actions.
The underlying issues that led to the derivative action (alleged misstatements regarding the Smart Sock) highlight potential reputational risks if not fully addressed by the new governance structure.

Future Outlook

The Company's future outlook is expected to be strengthened by the implementation of enhanced corporate governance, risk management, and disclosure controls, which are designed to prevent recurrence of past alleged issues and improve compliance with legal and regulatory requirements for at least the next eight years.

Industry Context

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Establishment of Board-Level Audit and Risk Committee	The Board will establish an Audit and Risk Committee with at least three independent members experienced in risk management. It will meet at least five times annually, oversee an Enterprise Risk Management (ERM) program, monitor risk management policies, compliance, internal risk assessments, and regulatory interactions. It will also oversee the Code of Business Conduct and Ethics, report on CEO/CFO ethics contributions, ensure whistleblower protection, and assume existing Audit Committee responsibilities.	Within 30 days after final settlement approval or at the Board's next regularly scheduled meeting, whichever is earlier.	Significantly enhances Board oversight of risk management, compliance, and ethical conduct, integrating these functions more deeply into strategic decision-making and reporting.
Establishment of Management-Level Enterprise Risk Management Committee (ERM Committee)	The Company will form an ERM Committee comprising the CEO, General Counsel, CTO, President, and CFO. It will have primary responsibility for assessing organizational risk, reporting significant compliance matters to the Audit and Risk Committee, making remedial recommendations, and preparing quarterly risk reports to the Board. It will also oversee cross-functional training on federal regulator interactions and conduct annual reviews of internal controls effectiveness.	In conjunction with the establishment of the Audit and Risk Committee.	Strengthens management's capability to identify, assess, monitor, and manage business risks, ensuring a more proactive and integrated approach to risk management across the organization.
Establishment of Management-Level Disclosure Committee	The Company will establish a Disclosure Committee (CEO, CFO, Controller, General Counsel as Chairperson) to ensure public disclosures are accurate, complete, timely, and compliant with laws. It will meet at least quarterly, maintain Disclosure Controls Policies and Procedures, evaluate disclosure controls effectiveness, assess materiality of information, review SEC filings and earnings call transcripts for accuracy, and report quarterly to the Board on disclosure risks. It will also provide sub-certifications to Certifying Officers.	Within 30 days after final settlement approval or at the Board's next regularly scheduled meeting, whichever is earlier.	Enhances the integrity and reliability of the Company's public disclosures, reducing the risk of future misstatements and improving transparency for investors.
Director Education Program	Each Board member must attend a National Association of Corporate Directors Certified Program (or similar) within one year of settlement approval and every two years thereafter. Newly elected members must attend within one year of joining. The General Counsel will also develop an annual internal education program covering GAAP, compliance, corporate governance, Sarbanes-Oxley Act, and board oversight best practices.	Within one year after final settlement approval for existing directors; within one year of joining for new directors.	Ensures that Board members possess up-to-date knowledge and expertise in critical areas such as financial reporting, compliance, and corporate governance, leading to more informed decision-making.
Director Board Limitations	The Corporate Governance Guidelines will be amended to require that, unless unanimously approved by the Board, independent directors sit on no more than three additional public company boards, and the Chair of the Board sit on no more than two other such boards.	Within 30 days after final settlement approval or at the Board's next regularly scheduled meeting, whichever is earlier.	Promotes greater focus and dedication from directors to Owlet's specific governance and oversight responsibilities, potentially improving board effectiveness.

Legal Proceedings

The filing details the preliminary approval of a settlement in the consolidated shareholder derivative action styled Vargas v. Workman, et al., Lead Case No. 2:24-cv-07258-FLA-PVC (C.D. Cal.).
This derivative action was brought on behalf of Owlet, Inc. against certain current and former directors and a stockholder, challenging statements regarding the 'Smart Sock' product.
A related securities class action, In re Owlet, Inc., Securities Litigation, Case No. 2:21-cv-09016-FLA-SSC (C.D. Cal.), reached an agreement-in-principle to resolve that action on December 2, 2024.

Stakeholder Impact

**Shareholders:** Benefit from the resolution of a legal dispute, removal of uncertainty, and significant enhancements to corporate governance, risk management, and disclosure practices, which are intended to protect shareholder value and improve long-term company stability.
**Management:** Will be subject to new and more stringent oversight structures and reporting requirements through the Audit and Risk Committee, ERM Committee, and Disclosure Committee, promoting greater accountability and compliance.
**Board of Directors:** Will have increased responsibilities and requirements, including mandatory education and limitations on external board service, aimed at improving their effectiveness and oversight capabilities.
**Employees:** The establishment of a whistleblower protection policy under the Audit and Risk Committee aims to foster a more ethical and compliant work environment.

Next Steps

Final approval of the settlement by the United States District Court for the Central District of California at the Settlement Hearing on February 6, 2026.
Owlet's Board to take all necessary actions to adopt, implement, and maintain the corporate governance reforms within 30 days after final approval or at the next regularly scheduled Board meeting, whichever is earlier.
Plaintiffs' Counsel to file their motion for final approval of the Settlement and application for attorneys' fees and service awards no later than seven calendar days before the objection deadline (January 23, 2026).

Key Dates

Date	Description
2024-08-26	Plaintiff Vargas filed a verified shareholder derivative complaint (Vargas Action).
2024-10-03	Plaintiff Capleton filed a verified shareholder derivative complaint (Capleton Action).
2024-11-11	Parties filed a joint stipulation and proposed order to consolidate Vargas and Capleton actions.
2024-12-02	Parties in the related Securities Class Action filed a notice of settlement.
2024-12-13	Court ordered consolidation of Vargas and Capleton actions into the Consolidated Action.
2025-01-07	Court entered Stipulation to Set Case Deadlines, requiring Plaintiffs to file an Amended Consolidated Complaint by February 7, 2025.
2025-02-07	Plaintiffs filed their Verified Consolidated Shareholder Derivative Complaint (Amended Complaint).
2025-02-28	Parties reached an agreement in principle on corporate governance reforms.
2025-03-03	Parties filed a Joint Notice of Settlement.
2025-03-28	Defendants produced documents to Plaintiffs to assess settlement fairness.
2025-04-02	Stipulation and Agreement of Settlement dated (Record Date for current stockholders).
2025-09-11	United States District Court for the Central District of California preliminarily approved the settlement.
2025-09-24	Date of signing of the 8-K report by Owlet, Inc.
2026-01-23	Deadline for objections to the settlement (14 days prior to Settlement Hearing).
2026-02-06	Settlement Hearing to determine final approval of the settlement, scheduled for 1:30 PM PT.

Recommendation

hold

The preliminary settlement of the derivative lawsuit removes a significant legal overhang and introduces substantial corporate governance reforms. While these changes are positive for long-term operational integrity and investor confidence, they do not directly impact the company's immediate financial performance or growth trajectory. The payment of legal fees is a known cost. Therefore, a 'hold' recommendation is appropriate as the company addresses past issues and strengthens its foundation, but without new information to suggest a significant change in its fundamental valuation or short-term prospects.

Keywords

Shareholder Derivative Litigation, Corporate Governance, SEC Filing, Settlement, Risk Management, Disclosure Controls, Audit Committee, Owlet, Smart Sock, Legal Proceedings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.